• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC ULTRA 8 IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN000255
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 02/21/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).There is an investigation ongoing into this reported complaint.A supplement follow-up mdr report will be submitted with the investigation results upon completion of the investigation.
 
Event or Problem Description
It was reported by the clinical support specialist (css) that the balloon ruptured.The staff had called about drain task incomplete alarms (approx.Every 20 minutes), which was not resolved with cycling the pump's power.The condensation collection bottle had very little condensate in it, and the staff noted blood in the helium driveline tubing.It was stated that the removal was difficult, the patient was taken to the operating room for femoral repair.They had to place a patch at the femoral bifurcation.
 
Additional Manufacturer Narrative
Qn#(b)(4).Teleflex received the device for investigation.The reported complaint that the "balloon ruptured" is confirmed.The intra-aortic balloon catheter (iabc) bladder had a full thickness abrasion, which caused the blood to enter the helium pathway.The appearance of the abraded area is consistent with repeated contact with calcified plaque on the aortic wall.The root cause of the bladder leak is related to patient condition.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risk.This will be monitored for any developing trends.
 
Event or Problem Description
It was reported by the clinical support specialist (css) that the balloon ruptured.The staff had called about drain task incomplete alarms (approx.Every 20 minutes), which was not resolved with cycling the pump's power.The condensation collection bottle had very little condensate in it, and the staff noted blood in the helium driveline tubing.It was stated that the removal was difficult, the patient was taken to the or for femoral repair.They had to place a patch at the femoral bifurcation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRA 8 IAB: 8FR 40CC
Common Device Name
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
16 elizabeth drive
chelmsford MA 01824
Manufacturer Contact
kaylia pen
16 elizabeth drive
chelmsford, MA 01824
MDR Report Key13869472
Report Number3010532612-2022-00076
Device Sequence Number20157495
Product Code DSP
UDI-Device Identifier00801902010759
UDI-Public00801902010759
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
K000729
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2023
Device Model NumberIPN000255
Device Catalogue NumberIAB-05840-U
Device Lot Number18F21H0050
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/04/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/21/2022
Supplement Date Received by Manufacturer04/12/2022
Initial Report FDA Received Date03/23/2022
Supplement Report FDA Received Date04/13/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/26/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NI.; NI.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-